{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:00:15Z","timestamp":1773284415247,"version":"3.50.1"},"reference-count":26,"publisher":"Korean Cancer Association","issue":"3","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2019R1A2C1088246"],"award-info":[{"award-number":["2019R1A2C1088246"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2022IL0014-1"],"award-info":[{"award-number":["2022IL0014-1"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["e-crt.org"],"crossmark-restriction":true},"short-container-title":["Cancer Res Treat"],"published-print":{"date-parts":[[2024,7,15]]},"abstract":"<jats:p>Purpose In this study, we aimed to determine the clinicopathologic, radiologic, and molecular significance of the tumor invasiveness to further stratify the patients with high-grade (HG) upper tract urothelial carcinoma (UTUC) who can be treated less aggressively. Materials and Methods Clinicopathologic and radiologic characteristics of 166 surgically resected HG UTUC (48 noninvasive, and 118 invasive) cases were evaluated. Six noninvasive UTUC cases with intratumoral tumor grade heterogeneity were selected for whole-exome sequencing (WES) to understand the underlying molecular pathophysiology. Barcode-tagging sequencing was done for validation of the target genes from WES data.Results Patients with noninvasive UTUC showed no cancer-specific death with better cancer-specific survival (p &lt; 0.001) and recurrence-free survival (p &lt; 0.001) compared to the patients with invasive UTUC. Compared to the invasive UTUC, noninvasive UTUC was correlated to a low grade (LG) on the preoperative abdominal computed tomography (CT) grading system (p &lt; 0.001), histologic intratumoral tumor grade heterogeneity (p=0.018), discrepancy in preoperative urine cytology diagnosis (p=0.018), and absence of urothelial carcinoma in situ (p &lt; 0.001). WES of the heterogeneous components showed mutually shared HRAS and FGFR3 mutations shared between the HG and LG components. HRAS mutation was associated with the lower grade on preoperative abdominal CT and intratumoral tumor grade heterogeneity (p=0.045 and p &lt; 0.001, respectively), whereas FGFR3 mutation was correlated to the absence of carcinoma in situ (p &lt; 0.001).ConclusionAccording to our comprehensive analysis, HG noninvasive UTUC can be preoperatively suspected based on distinct preoperative radiologic, cytologic, histologic, and molecular features. Noninvasive HG UTUC shows excellent prognosis and thus should be treated less aggressively.<\/jats:p>","DOI":"10.4143\/crt.2023.1150","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T07:30:16Z","timestamp":1703057416000},"page":"856-870","update-policy":"https:\/\/doi.org\/10.4143\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Invasiveness of Upper Tract Urothelial Carcinoma: Clinical Significance and Integrative Diagnostic Strategy"],"prefix":"10.4143","volume":"56","author":[{"given":"Bokyung","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kye Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumsik","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Mee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deokhoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2954","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.03.032"},{"key":"ref2","first-page":"1","volume-title":"Optimal management of upper tract urothelial carcinoma: current perspectives","author":"Leow","year":"2020"},{"key":"ref3","first-page":"1052","volume-title":"Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel","author":"Seisen","year":"2016"},{"key":"ref4","first-page":"17","volume-title":"Upper tract urinary cytology to detect upper tract urothelial carcinoma: Using the Johns Hopkins Hospital template and evaluation of its feasibility","author":"Chen","year":"2015"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14068"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.14.13167"},{"key":"ref7","first-page":"970","volume-title":"Genomic characterization of upper tract urothelial carcinoma","author":"Sfakianos","year":"2015"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.05.048"},{"key":"ref9","first-page":"793","volume-title":"Molecular classification and diagnostics of upper urinary tract urothelial carcinoma","author":"Fujii","year":"2021"},{"key":"ref10","volume-title":"","year":"2022"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-020-01877-w"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp324"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1101\/gr.107524.110"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2514"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-12-0095"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2307\/2336057"},{"key":"ref17","volume-title":"","author":"Harrell","year":"2015"},{"key":"ref18","first-page":"8108","volume-title":"FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder","author":"Bakkar","year":"2003"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038863"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-06-1182"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24072"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10873-y"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02230-w"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15885-7"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.09.003"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.16.16064"}],"container-title":["Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-crt.org\/upload\/pdf\/crt-2023-1150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-crt.org\/journal\/view.php?doi=10.4143\/crt.2023.1150","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-crt.org\/upload\/pdf\/crt-2023-1150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T01:38:03Z","timestamp":1721007483000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-crt.org\/journal\/view.php?doi=10.4143\/crt.2023.1150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"URL":"https:\/\/doi.org\/10.4143\/crt.2023.1150","relation":{},"ISSN":["1598-2998","2005-9256"],"issn-type":[{"value":"1598-2998","type":"print"},{"value":"2005-9256","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"2023-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-18","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-15","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}